Use of Intravenous Anakinra for Management of Pediatric Cytokine Storm Syndromes at an Academic Medical Center

Background: Off-label intravenous (IV) route of anakinra is increasingly recognized to enable higher and faster maximal plasma concentrations than subcutaneous route for treatment of cytokine storm syndromes. Objective: To describe off-label indications of IV anakinra, corresponding dosing and safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lirong, Lowry, Sandra, Heath, Travis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288450/
https://www.ncbi.nlm.nih.gov/pubmed/37360202
http://dx.doi.org/10.1177/00185787221142470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288450/
https://www.ncbi.nlm.nih.gov/pubmed/37360202
http://dx.doi.org/10.1177/00185787221142470

Ejemplares similares